Viscount Stansgate

Yes, the Parliament Acts apply to private members bills.

For information relating to the use of “His Majesty’s Government”, I refer the Noble Viscount to Question HC112168:

Question: To ask the Minister for the Cabinet Office, whether the Prime Minister, as the King's principal adviser, (a) was consulted on and (b) approved the decision to change the HM Government identity to the UK Government; and whether the Prime Minister was advised by Tim Allan in this regard when Mr Allan was Executive Director of Communications. 112168

Answer: There are no plans to discontinue the use of “HM Government”.

Please refer to https://www.communications.gov.uk/guidance/marketing/branding-guidelines/ for guidance on logo use. There are no plans to publish the revised guidance held by the Government Digital Service and the Government Communication Service.

Communications teams are advised to use "UK Government" rather than departmental names and logos for announcements, to provide clarity to the public. This does not affect the use of "His Majesty's Government", which continues on relevant official communications and records.

"UK Government" has long been the term used for the government in public-facing communications. All governments have regularly reviewed and updated government branding guidance to ensure that communications with the public are clear.

This guidance was developed in consultation with relevant stakeholders and in accordance with standard protocols in Summer 2025.

The Government takes the function of the Cabinet Manual seriously and we will keep it under review.

Following the statement made by Buckingham Palace on 30 October, the entitlement to the title of ‘Prince’ and the style of ‘Royal Highness’ has been removed by Letters Patent. The title of the Duke of York has been removed from the Roll of the Peerage and will no longer be used officially. There is therefore no need for legislation to implement the measures that have been announced.

The Counsellors of State Act 2022 added two additional Members of the Royal Family to the list of those eligible to act as Counsellors of State in order to provide greater resilience in this aspect of our constitutional arrangements.

In practice, reflecting a commitment made during the passage of the Act, only working Members of the Royal Family are called upon to act as Counsellors of State.

The Government has no plans to amend the Counsellors of State Act 2022.

The Titles Deprivation Act 1917 authorised enemies of the United Kingdom to be deprived of their peerages during the First World War.

The Government has no plans to amend the Titles Deprivation Act 1917.

The Government recognises the importance of the mathematical sciences. While delivery plans and funding allocations are prepared, the Engineering and Physical Sciences Research Council (EPSRC) which is part of UK Research and Innovation (UKRI), has made no additional commitments beyond existing planned investments, as set out in the response to HL14784.

The Department recognises the mathematical sciences is a key element for the advancement of all areas of science and technology. In 2025-2026, UK Research and Innovation (UKRI) committed £25 million to core mathematical sciences, alongside wider support through the Engineering and Physical Sciences Research Council (EPSRC), including, Centres for Doctoral Training (CDTs) in mathematical sciences and related areas.

UKRI’s current corporate plan for 2025-2027, published on 25th November 2025, includes the launch of new doctoral training awards to target priority areas, including £1 million for mathematical sciences through EPSRC.

The Government plan to publish a single UKRI Delivery Plan, which will provide an update on UKRI’s plans for the 2026-27 financial year.

The Department recognises the mathematical sciences is a key element for the advancement of all areas of science and technology. In 2025-2026, UK Research and Innovation (UKRI) committed £25 million to core mathematical sciences, alongside wider support through the Engineering and Physical Sciences Research Council (EPSRC), including, Centres for Doctoral Training (CDTs) in mathematical sciences and related areas.

UKRI’s current corporate plan for 2025-2027, published on 25th November 2025, includes the launch of new doctoral training awards to target priority areas, including £1 million for mathematical sciences through EPSRC.

The Government plan to publish a single UKRI Delivery Plan, which will provide an update on UKRI’s plans for the 2026-27 financial year.

The Department recognises the mathematical sciences is a key element for the advancement of all areas of science and technology. In 2025-2026, UK Research and Innovation (UKRI) committed £25 million to core mathematical sciences, alongside wider support through the Engineering and Physical Sciences Research Council (EPSRC), including, Centres for Doctoral Training (CDTs) in mathematical sciences and related areas.

UKRI’s current corporate plan for 2025-2027, published on 25th November 2025, includes the launch of new doctoral training awards to target priority areas, including £1 million for mathematical sciences through EPSRC.

The Government plan to publish a single UKRI Delivery Plan, which will provide an update on UKRI’s plans for the 2026-27 financial year.

Minister Hardy holds responsibility for issues involving light pollution.

We continue to monitor US Aviation industry concerns that the US 5G network could affect equipment onboard aircraft.

The UK Civil Aviation Authority (CAA) is leading on assessing any risks from the implementation of the UK 5G network on aviation safety, in conjunction with the Ministry of Defence, OFCOM, and industry stakeholders. The CAA has issued guidance to UK operators throughout the world on 5G status in other countries, including the US.

The UK CAA will continue to monitor the situation, and both my department and the CAA is in close contact with industry, the US Federal Aviation Administration, the EU Aviation Safety Agency and other stakeholders on this.

The Assessment of priority skills to 2030 report shows the proportion of employed learners that enter priority occupations across the ten priority sectors (eight industrial strategy sectors, adult social care, and construction). This assessment shows that 57% of learners with a degree (level 6) in mathematical sciences enter these priority occupations.

Whilst no formal assessment has been made, we have noted the Charter’s focus on quality standards of care, access to accurate information and equality.

Allergy services in England are commissioned through clinical commissioning groups to meet the needs of the local population. A small number of specialist allergy services for patients with rare and complex conditions are commissioned through NHS England and NHS Improvement’s specialised commissioning. The service specification specifies that centres provide equity of access to best practice standards for diagnosis and management, based on current national and international guidelines.

The Department and NHS England and NHS Improvement continue to engage with stakeholders to understand the needs of people with allergies and how services could be improved. This includes patient and public voice membership in NHS England and NHS Improvement’s clinical reference group which provides clinical advice and leadership on specialised immunology and allergy services.

The NHS COVID Pass can now be used to demonstrate proof of a booster or third dose for outbound international travel. This is visible through the NHS App and NHS.UK within the NHS COVID Pass for Travel.

The Therapeutics Taskforce is monitoring data from clinical trials taking place worldwide to assess whether ivermectin is a safe and effective treatment for COVID-19. Ivermectin is not currently a licensed treatment for COVID-19 and evidence from clinical trials as a treatment for COVID-19 is inconclusive. This assessment is based on the views of the Therapeutics Taskforce, the UK COVID-19 Therapeutics Advisory Panel and the Research to access pathway for investigational drugs for COVID-19. This assessment is also consistent with the views of the World Health Organization, the Food and Drug Administration and the European Medicines Agency. We will continue to keep this assessment under review as more data becomes available from clinical trials, including the Government-funded PRINCIPLE clinical trial.